Incyte to Present at the Leerink Partners Inaugural Immuno-Oncology Roundtable Conference

WILMINGTON, Del.--(BUSINESS WIRE)--

Incyte Corporation INCY announced today it will present at the Leerink Partners Inaugural Immuno-Oncology Roundtable Conference on Thursday, October 1, 2015 at 3:15 p.m. (EDT) in New York.

The presentation will be webcast live and can be accessed at www.incyte.com under Investor Relations, Events and Webcasts. Investors interested in listening to the live webcast should log on before the start time in order to download any software required. A replay of the presentation will be available.

About Incyte

Incyte Corporation is a Wilmington, Delaware-based biopharmaceutical company focused on the discovery, development and commercialization of proprietary therapeutics, primarily for oncology. For additional information on Incyte, please visit the Company's web site at www.incyte.com.

View source version on businesswire.com: http://www.businesswire.com/news/home/20150915005016/en/